1. Events & Learning
  2. Guidelines
  3. Improving Care
  4. News and Policy
  5. Membership
  6. About
Search
Search
  1. Events & Learning
  2. Guidelines
  3. Improving Care
  4. News and Policy
  5. Membership
  6. About
  1. COVID-19
  2. Journals
  3. eLearning
Sections

Overview

BSR's 'gold standard' clinical guidelines support evidence-based clinical practice in rheumatology.

Our guidelines are developed using the methods and processes outlined in Creating Clinical Guidelines: British Society for Rheumatology Protocol and overseen by our Guidelines Steering Group.

Our guidelines grow out of the collaborative efforts of many members and non-members, specialists and generalists and people with lived experience of the topic being covered. We also involve trainees in our guideline working groups as an important educational opportunity.

All guidelines are published in Rheumatology under an ‘open access’ licence.

To develop our guidelines, we partner with the University of Keele to support the evidence review process.

NICE accredits our clinical guideline process; this is valid until December 2023.
NICE accreditation logo
Get involved

Get involved in our guidelines

Get in touch

Pregnancy and breastfeeding: Part 1


Guideline on prescribing drugs in pregnancy and breastfeeding Part 1: immunomodulatory anti-rheumatic drugs and corticosteroids. 


2022 NICE-accredited

Executive Summary

Full guideline

Audit tool

Podcast

Rheumatology Roundtable Video 

System.Collections.Generic.List`1[Cantarus.Libraries.Dispatch.Models.TaxonomyTermDto]

Pregnancy and breastfeeding: Part 2


Guideline on prescribing drugs in pregnancy and breastfeeding Part 2: comorbidity medications used in rheumatology practice. 


2022 NICE-accredited

Executive Summary

Full guideline

Audit tool

Podcast

Scope

Rheumatology Roundtable Video

System.Collections.Generic.List`1[Cantarus.Libraries.Dispatch.Models.TaxonomyTermDto]

PsA with biologics/DMARDs


Guideline for the treatment of psoriatic arthritis with biologics and targeted synthetic DMARDs. 2022 NICE-accredited.
Executive summary

Full guideline

Audit tool

Summary cheat sheet

Summary algorithm slide

Podcast

Rheumatology Roundtable video

Scope

System.Collections.Generic.List`1[Cantarus.Libraries.Dispatch.Models.TaxonomyTermDto]

Paediatric, adolescent and adult patients with idiopathic inflammatory myopathy (myositis)


Guideline for the management of paediatric, adolescent and adult patients with idiopathic inflammatory myopathy (myositis). 2022 NICE-accredited.

Full guideline

Audit tool

Clinical updates podcast

What does it mean for patients podcast

Rheumatology Roundtable video

System.Collections.Generic.List`1[Cantarus.Libraries.Dispatch.Models.TaxonomyTermDto]

Hot swollen joint


Guideline for management of hot swollen joint in adults. 2006. Currently being considered for revision.

Executive summary

Full guideline

Hot Joint guideline update


System.Collections.Generic.List`1[Cantarus.Libraries.Dispatch.Models.TaxonomyTermDto]

Biological DMARD safety


Guideline for the safe prescribing of biologics in adults with inflammatory arthritis. 2019 NICE-accredited. Revision will be considered in 2023.

Executive summary

Full guideline


System.Collections.Generic.List`1[Cantarus.Libraries.Dispatch.Models.TaxonomyTermDto]

ANCA-associated vasculitis


Guideline for the management of adults with ANCA-associated vasculitis. 2014. Currently being considered for revision.

Executive summary

Full guideline and suggestions for audit


System.Collections.Generic.List`1[Cantarus.Libraries.Dispatch.Models.TaxonomyTermDto]

Gout


Guideline for the management of gout. 2017 NICE-accredited. Currently being considered for revision.

Executive summary

Full guideline

Audit tool

Podcast 2017  

Podcast 2023

Gout guideline blog

System.Collections.Generic.List`1[Cantarus.Libraries.Dispatch.Models.TaxonomyTermDto]

Giant cell arteritis


Guideline on the management of patients with giant cell arteritis. 2020 NICE-accredited. Revision will be considered in 2024.

Executive summary

Full Guideline

Audit tool


System.Collections.Generic.List`1[Cantarus.Libraries.Dispatch.Models.TaxonomyTermDto]

Foot health in inflammatory arthritis


Management of foot health in patients with inflammatory arthritis. 

Scope


System.Collections.Generic.List`1[Cantarus.Libraries.Dispatch.Models.TaxonomyTermDto]

Polymyalgia rheumatica


Guideline for the management of polymyalgia rheumatica. The 2009 guideline remains current. It is substantially the same as the 2015 EULAR/ACR guideline 'Recommendations for the Management of Polymyalgia Rheumatica'. Currently being considered for revision.

Executive summary

Full guideline

System.Collections.Generic.List`1[Cantarus.Libraries.Dispatch.Models.TaxonomyTermDto]

Sjögren’s syndrome


Guideline for the management of adults with primary Sjögren's syndrome. 2017 NICE-accredited. In revision.

Guideline scope


2017 guideline

Executive summary

Full guideline

Audit tool

Podcast


System.Collections.Generic.List`1[Cantarus.Libraries.Dispatch.Models.TaxonomyTermDto]

DMARDs


Guideline for the prescription and monitoring of non-biologic disease-modifying anti-rheumatic drugs. 2017 NICE-accredited. In revision.

Executive summary

Full guideline

Audit tool

Podcast


System.Collections.Generic.List`1[Cantarus.Libraries.Dispatch.Models.TaxonomyTermDto]

Lupus


Guideline for the management of adults with Systemic Lupus Erythematosus. 2017 NICE-accredited. In revision.

2023 guideline scope


2017 guideline

Executive summary

Full guideline

Audit tool

Podcast


System.Collections.Generic.List`1[Cantarus.Libraries.Dispatch.Models.TaxonomyTermDto]

Systemic sclerosis


Guideline for the treatment of systemic sclerosis. 2016 NICE-accredited. In revision.

2023 guideline scope

2016 guideline

Executive summary

Full guideline

Audit (See page 10 of the full GL for guidance on audit)

Podcast

System.Collections.Generic.List`1[Cantarus.Libraries.Dispatch.Models.TaxonomyTermDto]

Axial spondyloarthritis


Guideline for the treatment of axial spondyloarthritis (including ankylosing spondylitis) with biologics. 2016 NICE-accredited. In revision.

2023 Guideline Scope

2016 guideline

Executive summary

Full guideline

Audit tool

Podcast


System.Collections.Generic.List`1[Cantarus.Libraries.Dispatch.Models.TaxonomyTermDto]

Implementing guidelines

We want to hear your experiences of using the guidelines to help us spot patterns, create case studies and find solutions to problems.

How has care in your unit improved through implementation? What clinical issues have you resolved by using a guideline? Are you or your unit having problems implementing any part of the guidelines?

If there is anything else you would like to share with us about planning, creating, auditing or using the guidelines, please email guidelines@rheumatology.org.uk.

Sign up for our newsletter

Yes please
Privacy policy
Thank you for getting in touch!
Company No: 3470316 | Charity No: 1067124
© 2022 British Society for Rheumatology

Contact

British Society for Rheumatology Bride House, 18-20 Bride Lane, London, EC4Y 8EE
T: +44 (0) 20 7842 0900 E: bsr@rheumatology.org.uk
Company No: 3470316 | Charity No: 1067124
© 2022 British Society for Rheumatology
Our site uses cookies. By continuing to browse this site you are agreeing to our use of cookies. Our cookies do not collect personal information. For more information, please read our Privacy Policy OK